Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shen'ge Powder (also known as Shen Ge San or Renshen Gejie San) is a Traditional Chinese Medicine (TCM) formula composed of Ginseng (Ren Shen) and Gecko (Ge Jie). It is traditionally used to tonify the lungs and kidneys, particularly for treating chronic cough and asthma associated with kidney deficiency. Modern clinical research, as evidenced by several trials in the Chinese Clinical Trial Registry (ChiCTR), is exploring its efficacy in treating chronic heart failure, dilated cardiomyopathy, and stable chronic obstructive pulmonary disease (COPD). The formula is specifically indicated for patients with the Heart-Kidney Yang Deficiency syndrome, where it is believed to improve myocardial function and overall exercise tolerance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shen'ge Powder.